Stereotactic radiosurgery has an important role as primary or adjuvant therapy for selected cerebral vascular malformations and brain tumors. Over the next decade, both extended clinical experience, basic radiobiologic studies, and improvements in dose planning are expected to enhance its overall efficacy and safety.